Literature DB >> 24548231

Technical and clinical outcomes of ureteral stenting in cats with benign ureteral obstruction: 69 cases (2006-2010).

Allyson C Berent1, Chick W Weisse, Kimberly Todd, Demetrius H Bagley.   

Abstract

OBJECTIVE--To evaluate the technical, short-term, and long-term outcomes in cats with benign ureteral obstructions treated by means of double-pigtail ureteral stent placement. DESIGN--Retrospective case series. ANIMALS--69 cats (79 ureters). PROCEDURES--The diagnosis of benign ureteral obstruction was made via abdominal ultrasonography, radiography, and ureteropyelography. Ureteral stent placement was attempted endoscopically, surgically, or both, with fluoroscopic guidance. The medical records were reviewed for pre-, intra-, and postoperative data; complications; and outcome. RESULTS--69 cats (79 ureters) had stent placement attempted for various causes: ureterolithiasis (56/79 [71%]), stricture (10/79 [13%]), both ureterolithiasis and stricture (12/79 [15%]), or a purulent plug (1/79 [1%]). Stent placement was successful in 75 of 79 ureters (95%). Median number of stones per ureter was 4 (range, 0 to > 50), and 67 of 79 (85%) had concurrent nephrolithiasis. Preoperative azotemia was present in 95% (66/69) of cats (median creatinine concentration, 5.3 mg/dL [range, 1.1 to 25.8 mg/dL]), and 71% (49/69) remained azotemic (median, 2.1 mg/dL [range, 1.0 to 11.8 mg/dL]) after successful surgery. Procedure-related, postoperative (< 7 days), short-term (7 to 30 days), and long-term (> 30 days) complications occurred in 8.7% (6/69; 7/79 ureters), 9.1% (6/66), 9.8% (6/61), and 33% (20/60) of cats, respectively; most of these complications were minor and associated with intermittent dysuria or the need for ureteral stent exchange. The perioperative mortality rate was 7.5% (5/69), and no deaths were procedure related. The median survival time was 498 days (range, 2 to > 1,278 days). For patients with a renal cause of death, median survival time was > 1,262 days, with only 14 of 66 cats (21%) dying of chronic kidney disease. Nineteen (27%) cats needed a stent exchange (stricture in-growth [n = 10], migration [4], ureteritis [2], dysuria [2], pyelonephritis [1], or reflux [1]). No patient died of the procedure or recurrent ureteral obstruction. CONCLUSIONS AND CLINICAL RELEVANCE--Results of the present study indicated that ureteral stenting is an effective treatment for benign ureteral obstructions in cats regardless of obstructive location, cause, or stone number. The perioperative morbidity and mortality rates were lower than those reported with traditional ureteral surgery. The short- and long-term complications were typically minor but may necessitate stent exchange or use of an alternative device, particularly with ureteral strictures. The prognosis for feline ureteral obstructions after ureteral stenting could be considered good when the procedure is performed by trained specialists.

Entities:  

Mesh:

Year:  2014        PMID: 24548231     DOI: 10.2460/javma.244.5.559

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  15 in total

1.  Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.

Authors:  Akiko Watanabe; Keiichi Ohata; Tsuyoshi Oikawa; Takeshi Sugaya; Masao Miyazaki; Hiroshi Satoh; Masaaki Katayama
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

2.  Urolithiasis in cats: Evaluation of trends in urolith composition and risk factors (2005-2018).

Authors:  Lucy Kopecny; Carrie A Palm; Gilad Segev; Jennifer A Larsen; Jodi L Westropp
Journal:  J Vet Intern Med       Date:  2021-05-06       Impact factor: 3.175

3.  Clinical presentation and outcome of cats with circumcaval ureters associated with a ureteral obstruction.

Authors:  J Steinhaus; A C Berent; C Weisse; A Eatroff; T Donovan; J Haddad; D Bagley
Journal:  J Vet Intern Med       Date:  2014-09-30       Impact factor: 3.333

4.  Treatment of fungal pyelonephritis and ureterolithiasis with a subcutaneous ureteral bypass system and systemic antifungal medication in a cat.

Authors:  Rebecca G McQuitty; Erinne M Branter
Journal:  Vet Med (Auckl)       Date:  2018-11-27

5.  Use of a subcutaneous ureteral bypass device for treatment of bilateral proximal ureteral injury in a 9-month-old cat.

Authors:  Joseph A Sapora; Robert J Hardie; Natashia Evans
Journal:  JFMS Open Rep       Date:  2019-03-11

6.  Risk factors for positive urine cultures in cats with subcutaneous ureteral bypass and ureteral stents (2010-2016).

Authors:  Lucy Kopecny; Carrie A Palm; Kenneth J Drobatz; Ingrid M Balsa; William T N Culp
Journal:  J Vet Intern Med       Date:  2018-12-03       Impact factor: 3.333

7.  A giant ureteral stone in a 32-year-old man: a case report.

Authors:  Mohammad Natami; Alireza Makarem; Faisal Ahmed; Niloofar Dastgheib; Ali-Hossein Zahraei
Journal:  Int Med Case Rep J       Date:  2019-02-18

8.  Infection and extrusion of a subcutaneous access port in a cat: a long-term postoperative complication of a subcutaneous ureteral bypass device.

Authors:  Aurore Fouhety; Jean-François Boursier
Journal:  JFMS Open Rep       Date:  2020-04-14

9.  ACVIM Small Animal Consensus Recommendations on the Treatment and Prevention of Uroliths in Dogs and Cats.

Authors:  J P Lulich; A C Berent; L G Adams; J L Westropp; J W Bartges; C A Osborne
Journal:  J Vet Intern Med       Date:  2016-09-09       Impact factor: 3.333

10.  Therapeutic use of tetrasodium ethylenediaminetetraacetic acid solution for treatment of subcutaneous ureteral bypass device mineralization in cats.

Authors:  Colin Chik; Allyson C Berent; Chick W Weisse; Marcia Ryder
Journal:  J Vet Intern Med       Date:  2019-08-06       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.